| Literature DB >> 32414056 |
Luz Agulló-Chazarra1, Isabel Borrás-Linares2, Jesús Lozano-Sánchez2,3, Antonio Segura-Carretero2,4, Vicente Micol1,5, María Herranz-López1, Enrique Barrajón-Catalán1.
Abstract
In the cosmetic industry, there is a continuous demand for new and innovative ingredients for product development. In the context of continual renovation, both cosmetic companies and customers are particularly interested in compounds derived from natural sources due to their multiple benefits. In this study, novel and green-extractive techniques (pressurized solvent, supercritical CO2, and subcritical water extractions) were used to obtain three new extracts from sweet cherry stems, a byproduct generated by the food industry. The extracts were characterized by high-performance liquid chromatography coupled to quadrupole-time-of-flight mass spectrometry (HPLC-ESI-QTOF-MS), and 57 compounds, mainly flavonoids but also organic and phenolic acids, fatty acids, and terpenes, were identified. After analytical characterization, a multistep screening approach, including antioxidant, enzymatic, and photoprotective cellular studies, was used to select the best extract according to its benefits of interest to the cosmetics industry. The extract obtained with supercritical CO2 presented the best characteristics, including a wide antioxidant capacity, especially against lipid peroxyl and OH free radicals, as well as relevant photoprotective action and antiaging properties, making it a potential new ingredient for consideration in the development of new cosmetics.Entities:
Keywords: HPLC-ESI-QTOF-MS; antioxidant; byproduct; cosmetic; natural extract; sweet cherry
Year: 2020 PMID: 32414056 PMCID: PMC7278782 DOI: 10.3390/antiox9050418
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Figure 1Base peak chromatograms of the extracts from SC stems obtained by supercritical fluid extraction (SFE; scSFE), pressurized solvent extraction (PLE; scPLE), and subcritical water extraction (SWE; scSWE).
Analytical data obtained from high-performance liquid chromatography coupled to electrospray quadrupole-time-of-flight mass spectrometry (HPLC-ESI-QTOF-MS) analysis for SC extracts.
| Retention Time (min) | (M – H)– | Error (ppm) | Proposed Compound | Extracts | ||
|---|---|---|---|---|---|---|
| 1.91 | 195.0499 | 195.0510 | C6H11O7 | 5.7 | D-gluconic acid | scSWE |
| 1.99 | 191.0552 | 191.0561 | C7H11O6 | 5.0 | quinic acid | scSWE |
| 5.42 | 315.0702 | 315.0722 | C13H15O9 | 6.3 | protocatechuic acid hexoside | scSWE |
| 6.52 | 577.1381 | 577.1351 | C30H25O12 | −5 | proanthocyanidin B2 isomer 1 | scSFE |
| 6.81 | 341.0856 | 341.0878 | C15H17O9 | 6.6 | caffeic acid hexoside | scSFE, scSWE |
| 7.23 | 289.0732 | 289.0718 | C15H13O6 | −5.1 | (epi)catechin isomer 1 | scSFE, scPLE, scSWE |
| 7.31 | 401.1446 | 401.1453 | C18H25O10 | 1.7 | benzyl β-primeveroside | scSWE |
| 7.40 | 137.0243 | 137.0244 | C7H5O3 | 0.6 | salicylic acid | scSWE |
| 7.43 | 577.1381 | 577.1351 | C30H25O12 | −5.1 | proanthocyanidin B2 isomer 2 | scSFE |
| 7.54 | 771.1977 | 771.1989 | C33H39O21 | 1.6 | quercetin-rutinoside-glucoside | scSWE |
| 7.60 | 521.2002 | 521.2028 | C26H33O11 | 5.1 | dihydrodehydrodiconiferyl alcohol glucopyranoside | scSWE |
| 7.64 | 325.0930 | 325.0929 | C15H17O8 | −0.3 | scSFE, scPLE | |
| 7.74 | 449.1094 | 449.1089 | C21H21O11 | −1.1 | eriodictyol glucoside isomer 1 | scSWE |
| 7.81 | 165.0557 | 165.0557 | C15H17O8 | 0.4 | melilotic acid | scSWE |
| 7.83 | 289.0735 | 289.0718 | C15H13O6 | −5.9 | (epi)catechin isomer 2 | scSFE, scPLE |
| 7.88 | 449.1094 | 449.1089 | C21H21O11 | −1.1 | eriodictyol glucoside isomer 2 | scSWE |
| 8.16 | 195.0664 | 195.0663 | C10H11O4 | −0.8 | dihydroferulic acid | scSWE |
| 8.45 | 609.1482 | 609.1461 | C27H29O16 | −2.1 | rutin | scSFE, scSWE |
| 8.58 | 465.1073 | 465.1038 | C21H21O12 | −3.4 | epicatechin- | scSFE, scPLE, scSWE |
| 8.85 | 463.0903 | 463.0882 | C21H19O12 | −2.1 | quercetin-glucoside | scPLE, scSWE |
| 8.91 | 431.1011 | 431.0984 | C21H19O10 | −6.2 | genistein- | scSFE, scPLE, scSWE |
| 8.95 | 593.1534 | 593.1512 | C27H29O15 | −3.7 | kaempferol- | scSFE, scPLE, scSWE |
| 9.13 | 477.1076 | 477.1038 | C22H21O12 | −7.9 | isorhamnetin-glucoside | scSFE, scPLE |
| 9.15 | 431.1007 | 431.0984 | C21H19O10 | −5.3 | genistein- | scSFE, scPLE |
| 9.28 | 431.1004 | 431.0984 | C21H19O10 | −4.6 | genistein- | scSFE, scPLE, scSWE |
| 9.42 | 447.0955 | 447.0933 | C21H19O11 | −4.9 | kaempferol- | scSFE, scPLE, scSWE |
| 9.58 | 431.0995 | 431.0984 | C21H19O10 | −2.7 | genistein- | scSFE, scPLE |
| 9.75 | 433.1158 | 433.1140 | C21H21O10 | −4.1 | naringenin- | scSFE, scPLE, scSWE |
| 10.25 | 433.1123 | 433.1140 | C21H21O10 | 4.0 | naringenin- | scSFE, scPLE |
| 10.35 | 417.1182 | 417.1191 | C21H21O9 | 2.2 | liquiritin | scSWE |
| 10.69 | 433.1148 | 433.1140 | C21H21O10 | −1.7 | naringenin- | scSFE, scPLE |
| 10.74 | 447.1295 | 447.1297 | C22H23O10 | 0.3 | sakuranin | scSWE |
| 10.84 | 415.1064 | 415.1035 | C21H19O9 | −6.2 | chrysin- | scSFE, scPLE |
| 10.94 | 447.129 | 447.1297 | C22H23O10 | 1.6 | sakuranetin glucopyranoside | scSWE |
| 11.07 | 417.1204 | 417.1191 | C21H21O9 | −3.1 | sakuranetin xylopyranoside | scSWE |
| 11.17 | 433.1176 | 433.1140 | C21H21O10 | −8.2 | naringenin- | scSFE, scPLE |
| 11.27 | 417.1196 | 417.1191 | C21H21O9 | −1.2 | prupersin B | scSWE |
| 11.62 | 447.1307 | 447.1297 | C22H23O10 | −2.4 | dihydrowogonin glucoside | scSWE |
| 12.39 | 327.2175 | 327.2177 | C18H31O5 | 0.6 | trihydroxy-octadecadienoic acid | scSFE, scPLE, scSWE |
| 12.78 | 433.1161 | 433.1140 | C21H21O10 | −4.9 | naringenin- | scSFE, scPLE |
| 13.04 | 329.2346 | 329.2333 | C18H33O5 | −3.8 | trihydroxy-octadecenoic acid | scSFE, scPLE, scSWE |
| 13.23 | 271.0607 | 271.0612 | C15H11O5 | 1.7 | naringenin isomer 1 | scSFE, scPLE, scSWE |
| 13.53 | 271.0600 | 271.0612 | C15H11O5 | 4.2 | naringenin isomer 2 | scSFE, scPLE |
| 14.35 | 517.3187 | 517.3171 | C30H45O7 | −3.2 | jaligonic acid | scSFE, scPLE |
| 15.74 | 501.3250 | 501.3222 | C30H45O6 | −5.7 | hydroxyceanothic acid isomer 1 | scSFE, scPLE |
| 16.14 | 253.0503 | 253.0506 | C15H9O4 | 1.4 | chrysin | scSFE, scPLE, scSWE |
| 16.31 | 285.0775 | 285.0768 | C16H13O5 | −2.3 | methylnaringenin | scSFE, scPLE, scSWE |
| 16.44 | 255.0644 | 255.0663 | C15H11O4 | 7.3 | pinocembrin | scSFE, scPLE, scSWE |
| 16.77 | 501.3238 | 501.3222 | C30H45O6 | −3.2 | hydroxyceanothic acid isomer 2 | scSFE, scPLE |
| 19.53 | 293.2122 | 293.2122 | C18H29O3 | 0.0 | hydroxy-octadecatrienoic acid isomer 1 | scSFE, scPLE |
| 19.87 | 293.2104 | 293.2122 | C18H29O3 | 6.1 | hydroxy-octadecatrienoic acid isomer 2 | scSFE, scPLE |
| 21.52 | 295.2291 | 295.2279 | C18H31O3 | −4.2 | hydroxy-octadecadienoic acid | scSFE, scPLE |
| 23.21 | 293.2111 | 293.2122 | C18H29O3 | 3.7 | hydroxy-octadecatrienoic acid isomer 3 | scSFE, scPLE |
| 30.02 | 277.2182 | 277.2173 | C18H29O2 | −3.4 | linolenic acid | scSFE, scPLE |
| 31.41 | 455.3528 | 455.3531 | C30H47O3 | 0.7 | ursolic acid | scSWE |
| 33.64 | 279.2327 | 279.2330 | C18H31O2 | 1.1 | linoleic acid | scSFE, scPLE |
| 34.06 | 299.2590 | 299.2592 | C18H35O3 | 0.4 | hydroxy-octadecanoic acid | scSFE, scPLE |
Relative peak areas of the identified compounds in SC stem extracts expressed as mean ± standard deviation of the three analyses replicates (ND: non-detected compound). For each compound, the best extractive technique is marked in bold format. PLE: pressurized liquid extraction, SWE: subcritical water extraction, SFE: supercritical fluid extraction.
| Proposed Compound | Peak Area x E+4 | ||
|---|---|---|---|
| PLE | SFE | SWE | |
|
| |||
| D-gluconic acid | ND | ND |
|
| quinic acid | ND | ND |
|
| caffeic acid hexoside |
| ND | 2.2 ± 0.2 |
|
| 4.0 ± 0.2 | ND | |
| protocatechuic acid hexoside | ND | ND |
|
| salicylic acid | ND | ND |
|
| melilotic acid | ND | ND |
|
| dihydroferulic acid | ND | ND |
|
|
| |||
| (epi)catechin–(epi)catechin (proanthocyanidin B2) isomer 1 |
| ND | ND |
| (epi)catechin isomer 1 |
| 282.0 ± 23.0 | 5.5 ± 0.3 |
| (epi)catechin–(epi)catechin (proanthocyanidin B2) isomer 2 |
| ND | ND |
| (epi)catechin isomer 2 |
| 44 ± 4 | ND |
| rutin |
| ND | 13.4 ± 0.4 |
| epicatechin-O-glucuronide |
| 20.0 ± 0.5 | 25.0 ± 1.0 |
| quercetin-glucoside |
| ND | 11.0 ± 1.0 |
| genistein-O-glucoside isomer 1 |
| 12.0 ± 0.5 | 27.8 ± 0.9 |
| kaempferol-O-rutinoside |
| 4.0 ± 0.2 | 6.3 ± 0.5 |
| isorhamnetin-glucoside |
| 3.0 ± 0.3 | ND |
| genistein-O-glucoside isomer 2 |
| 16.0 ± 1.0 | ND |
| genistein-O-glucoside isomer 3 |
| 24.0 ± 1.0 | 8.4 ± 0.3 |
| kaempferol-O-glucoside |
| 8.0 ± 0.2 | 4.6 ± 0.6 |
| genistein-O-glucoside isomer 4 |
| 17.0 ± 1.0 | ND |
| naringenin-O-glucoside isomer 1 |
| 34.0 ± 1.0 | 38 ± 1 |
| naringenin-O-glucoside isomer 2 |
| 40.0 ± 1.0 | ND |
| naringenin-O-glucoside isomer 3 |
| 34.0 ± 4.0 | ND |
| chrysin-O-glucoside |
| 180.0 ± 1.0 | ND |
| naringenin-O-glucoside isomer 4 |
| 49.0 ± 5.0 | ND |
| naringenin-O-glucoside isomer 5 | 6.0 ± 0.0 |
| ND |
| naringenin isomer 1 |
| 13.0 ± 0.8 | 8.8 ± 0.2 |
| naringenin isomer 2 |
| 5 ± 0.4 | ND |
| chrysin | 143.0 ± 12.0 |
| 3.8 ± 0.8 |
| methylnaringenin | 39.0 ± 2.0 |
| 3.0 ± 0.3 |
| benzyl β-primeveroside | ND | ND |
|
| quercetin-rutinoside-glucoside | ND | ND |
|
| dihydrodehydrodiconiferyl alcohol glucopyranoside | ND | ND |
|
| eriodictyol-glucoside isomer 1 | ND | ND |
|
| eriodictyol-glucoside isomer 2 | ND | ND |
|
| liquiritin | ND | ND |
|
| sakuranin | ND | ND |
|
| sakuranetin-glucopyranoside | ND | ND |
|
| sakuranin-xylopyranoside | ND | ND |
|
| prupersin B | ND | ND |
|
| dihydrowogonin glucoside | ND | ND |
|
| pinocembrin | ND | ND |
|
|
| |||
| trihydroxy-octadecadienoic acid |
| 29.0 ± 2.0 | 11.6 ± 0.6 |
| trihydroxy-octadecenoic acid |
| 40.0 ± 2.0 | 7.4 ± 0.2 |
| hydroxy-octadecatrienoic acid isomer 1 | 19.0 ± 0.3 |
| ND |
| hydroxy-octadecatrienoic acid isomer 2 | 9.0 ± 0.5 |
| ND |
| hydroxy-octadecadienoic acid | 76.0 ± 2.0 |
| ND |
| hydroxy-octadecatrienoic acid isomer 3 | 57.0 ± 4.0 |
| ND |
| linolenic acid | 129.0 ± 15.0 |
| ND |
| linoleic acid | 129.0 ± 2.0 |
| ND |
| hydroxy-octadecanoic acid | 13.0 ± 0.3 |
| ND |
|
| |||
| jaligonic acid |
| 297.0 ± 10.0 | ND |
| ursolic acid | ND | ND |
|
| hydroxyceanothic acid isomer 1 |
| 273.0 ± 6.0 | ND |
| hydroxyceanothic acid isomer 2 | 54.0 ± 3.0 |
| ND |
Figure 2Semiquantitative data regarding the different families of compounds extracted by SFE (scSFE), PLE (scPLE), and SWE (scSWE).
Percentage of gallic acid equivalents (GAE) ± standard deviation (SD) determined by the Folin-Ciocalteu assay and antioxidant capacity in millimole (mmol) Trolox eq./100 g extract ± SD, determined through Trolox equivalent antioxidant capacity (TEAC) for scSFE, scPLE, and scSWE.
| Extract | Folin % GAE (w/w) | TEAC mmol Trolox eq./100 g Extract |
|---|---|---|
| scSFE | 15.26 ± 2.94 | 240.61 ± 11.74 |
| scPLE | 18.81 ± 2.36 | 220.53 ± 13.57 |
| scSWE | 5.49 ± 1.16 | 70.38 ± 3.89 |
Antioxidant capacity of scSFE and scPLE by different methods: ferric reduction antioxidant power (FRAP) and oxygen radical absorbance capacity (ORAC), giving the antioxidant capacities compared to FeSO4 and Trolox, respectively. All the results are presented as the mean ± SD.
| Extract | FRAP mmol FeSO4 eq./100 g Extract | ORAC mmol Trolox eq./100 g Extract |
|---|---|---|
| scSFE | 64.83 ± 6.32 | 107.77 ± 5.76 |
| scPLE | 203.94 ± 8.37 | 64.15 ± 1.04 |
Antioxidant capacity of scSFE. The results showed its activity against lipid peroxidation through a thiobarbituric acid reactive substances (TBARS) assay (% inhibition of lipid peroxidation of 5 mg/mL of extract), the hydroxyl radical capacity as determined by an ORACOH assay (as µmol quercetin eq./g extract), and the capacity of the extract (200 µg/mL) to deplete nitric oxide (% depletion). All the results are presented as the mean ± SD.
| TBARS | ORACOH | % NO· Depletion | |
|---|---|---|---|
| scSFE | 45.13 ± 10.84 | 189.10 ± 0.81 | 29.37 ± 0.01 |
Determination of the inhibition (%) ± SD of collagenase, tyrosinase, elastase, hyaluronidase, and glycosylation by scSFE. ** (p < 0.01) and **** (p < 0.0001) indicate statistically significant differences compared to the corresponding untreated negative control; ns: not statistically significant.
| Percentage of Inhibition | |||||
|---|---|---|---|---|---|
| Extract | Collagenase | Tyrosinase | Elastase | Hyaluronidase | Glycosylation |
| scSFE | −11.76 ± 2.71 ns | 40.47 ± 19.35 ns | 164.11 ± 27.33 ** | 90.80 ± 5.93 **** | 51.76 ± 7.06 **** |
Figure 3Effect of scSFE extract (100 or 200 µg/mL) on viability after UVB (800 and 1200 J/m2) irradiation. Data are expressed as the mean of six replicates ± SD. * (p < 0.05), *** (p < 0.001), and **** (p < 0.0001) indicate statistically significant differences compared to an irradiated sample in the absence of the extract. Each condition is normalized with respect to its non-irradiated control.
Figure 4Determination of the antioxidant effects of scSFE related to UVA- (A) and UVB- (B) induced reactive oxygen species (ROS) generation in HaCaT cells. Fluorescence was normalized to non-irradiated controls. The white bars indicate the fluorescence signal in the absence of treatment for each condition. The data are expressed as the mean ± SD (n = 6). * (p < 0.05) and **** (p < 0.0001) indicate significant differences compared with irradiated cells at the same UVA dose (3 or 6 J/cm2) or UVB dose (800 or 1200 J/m2) in the absence of scSFE.